Flora Growth Corp. ( (FLGC) ) has released its Q4 earnings. Here is a breakdown of the information Flora Growth Corp. presented to its investors.
Flora Growth Corp. is a NASDAQ-listed company focused on cannabis-related consumer-packaged goods and pharmaceutical distribution, operating across 50 states and 28 countries with over 20,000 distribution points globally.
In its latest earnings report for the year ending December 31, 2024, Flora Growth Corp. highlighted strategic expansions and leadership changes, including the appointment of industry pioneer Sammy Dorf as Executive Chairman, signaling a robust push into the THC-infused beverage market.
Key financial metrics revealed a net loss from continuing operations of $15.9 million, a significant improvement from the previous year’s $46.7 million loss. Operating expenses were reduced to $28.1 million from $68.1 million, although the adjusted EBITDA loss increased to $9.5 million from $6.9 million. The company also reported successful product launches and partnerships, including the introduction of THC-infused beverages and a supply agreement with Curaleaf Holdings for the German market.
Looking ahead, Flora Growth Corp. is optimistic about the potential for cannabis reform in the U.S. under the re-elected President Donald Trump, which could provide regulatory clarity and market expansion opportunities. The company is also focused on expanding its footprint in Europe, particularly in Germany, and enhancing its product offerings through strategic partnerships and innovative product launches.